Session Information
2009 BIO International Convention
Click here to go to the previous page
Fast Forwarding Life Science Innovation: What Works, What Doesn't, Where Do We Go From Here?
Track : Global Biotechnology Issues
Program Code: 3097
Date: Wednesday, May 20, 2009
Time: 8:00 AM to 9:30 AM  EST
Location: B312
SPEAKER (S):
Anna Barker, PhD, National Cancer Institute
Zorina Galis, PhD, Amplinovia
John Hamer, PhD, Burrill & Company
Jan Lundberg, PhD, AstraZeneca, Research & Development, Inc
Ajit Singh, PhD, BioImagene, Inc
Douglas Throckmorton, MD, Deputy Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Krisztina Zsebo, PhD, Celladon Corporation
Description
Unmet medical needs persist despite the progress of life science innovation. The session brings together representatives from major stakeholders in the process of life science innovation who will present, in an interactive format, their own experiences with implementation of various solutions and their perspectives on remaining barriers to innovation. Panelists and the audience will brainstorm on applicability of global innovation trends (e.g., orchestrating, partnering, licensing, crowd-sourcing) to life sciences and on future improvements. Share your thoughts ahead of time at http://constructiveinterference.wordpress.com/ (look for the BIO2009 tag).

• Present various perspectives on life science innovation and share insight from implementation of various models
• Identify major remaining challenges for realizing innovation
• Propose solutions to further enable life science innovation


Audio Synchronized to PowerPoint
(Code: 3097)
  
This session is a part of: